Impact of Pneumococcal Vaccination on Pneumonia Hospitalizations and Related Costs in Ontario: A Population-Based Ecological Study | Zendy

Dara Lee Luca | Zendy; Jeffrey C. Kwong | Zendy; Anna Chu | Zendy; Beate Sander | Zendy; Ryan O’Reilly | Zendy; Allison McGeer | Zendy; David E. Bloom | Zendy

Open Access

Impact of Pneumococcal Vaccination on Pneumonia Hospitalizations and Related Costs in Ontario: A Population-Based Ecological Study

Author(s) -

Dara Lee Luca,

Jeffrey C. Kwong,

Anna Chu,

Beate Sander,

Ryan O’Reilly,

Allison McGeer,

David E. Bloom

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix850

Subject(s) - medicine , vaccination , pneumonia , pneumococcal conjugate vaccine , pneumococcal pneumonia , population , confidence interval , public health , vaccination policy , pneumococcal vaccination , pediatrics , environmental health , demography , streptococcus pneumoniae , immunology , nursing , sociology , biology , bacteria , genetics

In Ontario, Canada, pneumococcal conjugate vaccine (PCV) was approved for infants in 2001 and became part of the publicly funded routine immunization schedule in 2005. We assessed the population-level impact of PCV on pneumonia hospitalizations and related costs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research